A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
- Conditions
- HIV Infections
- Registration Number
- NCT00002411
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
The purpose of this study is to compare the safety of didanosine plus stavudine plus nelfinavir (NLF) with that of zidovudine plus lamivudine plus NLF. This study also examines how long these drug combinations are effective in lowering viral load (level of HIV in the blood).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (32)
Sorra Research Ctr / Med Forum
🇺🇸Birmingham, Alabama, United States
Body Positive
🇺🇸Phoenix, Arizona, United States
Hill Top Research Inc
🇺🇸Fresno, California, United States
UCLA Med Ctr / CARE BH-412 CHS
🇺🇸Los Angeles, California, United States
AIDS Healthcare Foundation
🇺🇸Los Angeles, California, United States
West Los Angeles VAMC
🇺🇸Los Angeles, California, United States
Sherman Oaks Hosp Research Institute
🇺🇸Sherman Oaks, California, United States
Harbor UCLA Med Ctr / Research and Educational Institute
🇺🇸Torrance, California, United States
Yale New Haven Hosp / Nathan Smith Clinic
🇺🇸New Haven, Connecticut, United States
GW Med Ctr / Clinical Trials Unit
🇺🇸Washington, District of Columbia, United States
Scroll for more (22 remaining)Sorra Research Ctr / Med Forum🇺🇸Birmingham, Alabama, United States